Published in Br J Hosp Med (Lond) on September 01, 2013
Prophylactic mastectomy and breast cancer. Br J Hosp Med (Lond) (2013) 1.07
Prophylactic mastectomy and breast cancer-- reply. Br J Hosp Med (Lond) (2013) 0.75
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology (2008) 8.10
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64
Intercellular Connection between Smooth Muscle Cells: the Nexus. Science (1962) 6.27
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
COMPLEMENT IN INFECTIOUS DISEASE IN MAN. J Clin Invest (1946) 2.75
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ (1998) 2.58
Electrical transmission at the nexus between smooth muscle cells. J Gen Physiol (1968) 2.54
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet (1999) 2.41
Location of gene for Gorlin syndrome. Lancet (1992) 2.41
Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene (2001) 2.36
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res (1997) 2.27
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
Li-Fraumeni syndrome--a molecular and clinical review. Br J Cancer (1997) 2.14
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet (2009) 2.05
Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med (1991) 1.97
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin. Infect Immun (1970) 1.87
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol (1990) 1.74
Production of heat-stable, methanol-soluble enterotoxin by Yersinia enterocolitica. Infect Immun (1979) 1.73
Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol (1996) 1.72
Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71
The resistance of the septum of the median giant axon of the earthworm. J Gen Physiol (1977) 1.71
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
Germline SDHD mutation in familial phaeochromocytoma. Lancet (2001) 1.62
A clinical study of type 1 neurofibromatosis in north west England. J Med Genet (1999) 1.62
A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61
The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet (1999) 1.61
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer (1998) 1.60
Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg (1998) 1.59
Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infection. Gastroenterology (1992) 1.59
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene (1998) 1.59
Inhibition of immune hemolysis: serological assay for the heat-labile enterotoxin of Excherichia coli. J Clin Microbiol (1977) 1.58
Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther (2000) 1.58
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. Hum Mol Genet (1996) 1.57
Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. Am J Hum Genet (1999) 1.57
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet (2000) 1.56
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol (1989) 1.52
Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathog (1991) 1.52
Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet (1999) 1.51
Molecular genetic tests in surgical management of familial adenomatous polyposis. Lancet (1997) 1.50
Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology (1993) 1.49
Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet (2000) 1.49
The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer (1997) 1.49
Can hair be used to screen for breast cancer? J Med Genet (2000) 1.49
Factors influencing the removal of fluoride from aqueous solution by calcined Mg-Al-CO3 layered double hydroxides. J Hazard Mater (2005) 1.49
Neutrophil-specific 99mTc-labeled anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis. J Nucl Med (2000) 1.48
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer (2006) 1.48
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology (1992) 1.47
Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol (1990) 1.47
Outcome from surgery for vestibular schwannomas in children. Br J Neurosurg (2009) 1.47
Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol (1991) 1.44
Screening by mammography, women with a family history of breast cancer. Eur J Cancer (1998) 1.44
Colonoscopy screening compliance and outcomes in patients with Lynch syndrome. Colorectal Dis (2015) 1.40
Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med (1983) 1.39
There may never be a final cure for breast cancer. Eur J Surg Oncol (2001) 1.39
Influence of media supplements on growth and survival of Campylobacter pylori. Eur J Clin Microbiol Infect Dis (1989) 1.39
Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology (1984) 1.38
Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology (1991) 1.36